by Krisha McCoy, MS
Aluminum toxicity occurs when a person ingests or breathes high levels of aluminum into the body.
Aluminum is the most plentiful metal in the earth’s crust. It is present in the environment combined with other elements such as oxygen, silicon, and fluorine.
Exposure to aluminum is usually not harmful, but exposure to high levels can cause serious health problems. If you think you have been exposed to high levels of aluminum, contact your doctor.
Because aluminum is found in food, water, air, and soil, people may be exposed to high levels of aluminum when they:
Anyone can develop this condition, but certain people are more likely to develop aluminum toxicity. The following factors increase your chances of developing aluminum toxicity:
If you have any of the following symptoms, see your doctor, especially if you have kidney disease or are on dialysis:
Complications may include:
The doctor will ask about symptoms and past health. A physical exam will be done. Tests may include:
Symptoms and blood tests will suggest aluminum toxicity. Aluminum in the bone marrow will confirm the diagnosis.
Talk with your doctor about the best treatment plan for you. Treatment options include:
The medication, deferoxamine mesylate, may be given to help eliminate aluminum from your body. This substance works through a procedure known as chelation, which helps the body remove poisonous materials.
You will be instructed on how to avoid exposure to excess aluminum from your diet and other sources.
To help reduce your chances of getting aluminum toxicity, take steps to avoid the following if they contain aluminum:
Talk to your doctor about your risk of aluminum poisoning from dialysis and total parenteral nutrition solutions.
Agency for Toxic Substances and Disease Registry
Environmental Protection Agency
Association of the Chemical Profession of Ontario
Guide to Less Toxic Products
Bia MJ, Cooper K, Schnall S, et al. Aluminum induced anemia: pathogenesis and treatment in patients on chronic dialysis. Kidney Int. 1989;36(5):852-858.
Cannata Andia JB. Aluminum toxicity: its relationship with bone and iron metabolism. Nephrol Dial Transplant. 1996;11 Suppl 3:69-73.
Delmez J, Weerts C, Lewis-Finch J, Windus D, Slatopolsky E. Accelerated removal of deferoxamine mesylate-chelated aluminum by charcoal hyperfusion in hemodialysis patients. Am J Kidney Dis. 198;13(4):308-311.
D’Haese PC, Couttenye MM, Goodman WG, et al. Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminum-related bone disease, increased risk for aluminum toxicity, or aluminium overload. Nephrol Dial Transplant. 1995;10:1874-1884.
Kawahara M. Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases. J Alzheimers Dis. 2005;8(2):171-182.
Krewski D, Yokei RA, Nieboer E et al: Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J Toxicol Environ Health B Crit Rev. 2007:10 supl 1: 1-269.
Malluche HH. Aluminum and bone disease in chronic renal failure. Nephrol Dial Transplant. 2002;17 Suppl 2:21-24.
Molloy DW, Standish TI, Nieboer E et al: Effects of acute exposure to aluminum on cognition in humans. J Toxicol Environ Health A 2007:70(23):2011-2019.
Toxic substances portal: Aluminum. Centers for Disease Control and Prevention website. Available at:
...(Click grey area to select URL)
Accessed March 29, 2020.
Last reviewed March 2020 by EBSCO Medical Review Board James Cornell, MD
Last Updated: 8/14/2020
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.